Clinical Report: Investigating Circular RNAs and MicroRNAs in NSCLC
Overview
This editorial discusses the roles of circular RNAs and microRNAs in non-small cell lung cancer (NSCLC). Key studies reveal the oncogenic functions of specific circRNAs and miRNAs, which correlate with disease progression and patient outcomes.
Background
Lung cancer is the leading malignancy globally, with substantial incidence and mortality rates. Non-small cell lung cancer (NSCLC) is the most prevalent subtype, and understanding the molecular mechanisms involved is crucial for improving patient outcomes. Non-coding RNAs, including circular RNAs and microRNAs, play roles in oncogenic processes.
Data Highlights
No numerical data or trial data presented in the source material.
Key Findings
CircUBE2G1 is upregulated in lung adenocarcinoma and associated with lymph node metastasis and poorer survival outcomes (Li et al., 2023).
Circ_0001859 is significantly upregulated in NSCLC and correlates with advanced TNM stage and lymph node metastasis (Tan et al., 2023).
High expression of miR-20a-5p predicts favorable disease-specific survival in NSCLC patients, while miR-17-5p is linked to poor prognosis in node-negative patients (Førde et al., 2023).
MiR-155 modulates cancer cell proliferation, migration, invasion, and chemotherapy resistance in NSCLC (Wei et al., 2023).
Clinical Implications
The findings suggest that circular RNAs and microRNAs could serve as valuable biomarkers for prognosis and therapeutic targets in NSCLC. Further research is needed to integrate these molecular insights into clinical practice.
Conclusion
The exploration of circular RNAs and microRNAs in NSCLC provides critical insights into their roles in tumor biology and potential therapeutic applications. Continued research may enhance diagnostic and treatment strategies for this prevalent cancer.
